These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22841289)

  • 1. Liver fat quantification by dual-echo MR imaging outperforms traditional histopathological analysis.
    Fischer MA; Raptis DA; Montani M; Graf R; Clavien PA; Nanz D; Alkadhi H; Scheffel H
    Acad Radiol; 2012 Oct; 19(10):1208-14. PubMed ID: 22841289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive quantification of hepatic steatosis in living, related liver donors using dual-echo Dixon imaging and single-voxel proton spectroscopy.
    Krishan S; Jain D; Bathina Y; Kale A; Saraf N; Saigal S; Choudhary N; Baijal SS; Soin A
    Clin Radiol; 2016 Jan; 71(1):58-63. PubMed ID: 26555703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 3D two-point Dixon and standard 2D dual-echo breath-hold sequences for detection and quantification of fat content in renal angiomyolipoma.
    Rosenkrantz AB; Raj S; Babb JS; Chandarana H
    Eur J Radiol; 2012 Jan; 81(1):47-51. PubMed ID: 21126839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy.
    Levenson H; Greensite F; Hoefs J; Friloux L; Applegate G; Silva E; Kanel G; Buxton R
    AJR Am J Roentgenol; 1991 Feb; 156(2):307-12. PubMed ID: 1898804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging.
    Mashhood A; Railkar R; Yokoo T; Levin Y; Clark L; Fox-Bosetti S; Middleton MS; Riek J; Kauh E; Dardzinski BJ; Williams D; Sirlin C; Shire NJ
    J Magn Reson Imaging; 2013 Jun; 37(6):1359-70. PubMed ID: 23172799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic fat quantification using chemical shift MR imaging and MR spectroscopy in the presence of hepatic iron deposition: validation in phantoms and in patients with chronic liver disease.
    Lee SS; Lee Y; Kim N; Kim SW; Byun JH; Park SH; Lee MG; Ha HK
    J Magn Reson Imaging; 2011 Jun; 33(6):1390-8. PubMed ID: 21591008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance and accuracy of 3-D spoiled gradient-dual-echo MRI with water- and fat-signal separation in liver-fat quantification: comparison to liver biopsy.
    Fischer MA; Nanz D; Reiner CS; Montani M; Breitenstein S; Leschka S; Alkadhi H; Stolzmann P; Marincek B; Scheffel H
    Invest Radiol; 2010 Aug; 45(8):465-70. PubMed ID: 20479652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2* relaxation effects.
    Kühn JP; Evert M; Friedrich N; Kannengiesser S; Mayerle J; Thiel R; Lerch MM; Dombrowski F; Mensel B; Hosten N; Puls R
    Invest Radiol; 2011 Dec; 46(12):783-9. PubMed ID: 21808200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-phase and out-of-phase gradient-echo imaging in abdominal studies: intra-individual comparison of three different techniques.
    Ramalho M; Herédia V; de Campos RO; Dale BM; Azevedo RM; Semelka RC
    Acta Radiol; 2012 May; 53(4):441-9. PubMed ID: 22535885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging.
    Schuchmann S; Weigel C; Albrecht L; Kirsch M; Lemke A; Lorenz G; Warzok R; Hosten N
    Eur J Radiol; 2007 Jun; 62(3):416-22. PubMed ID: 17267159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat quantification using three-point dixon technique: in vitro validation.
    Kovanlikaya A; Guclu C; Desai C; Becerra R; Gilsanz V
    Acad Radiol; 2005 May; 12(5):636-9. PubMed ID: 15866138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study assessing differentiation of steatosis hepatis, hepatic iron overload, and combined disease using two-point dixon MRI at 3 T: in vitro and in vivo results of a 2D decomposition technique.
    Boll DT; Marin D; Redmon GM; Zink SI; Merkle EM
    AJR Am J Roentgenol; 2010 Apr; 194(4):964-71. PubMed ID: 20308498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging and spectroscopy for monitoring liver steatosis.
    Cowin GJ; Jonsson JR; Bauer JD; Ash S; Ali A; Osland EJ; Purdie DM; Clouston AD; Powell EE; Galloway GJ
    J Magn Reson Imaging; 2008 Oct; 28(4):937-45. PubMed ID: 18821619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging.
    Borra RJ; Salo S; Dean K; Lautamäki R; Nuutila P; Komu M; Parkkola R
    Radiology; 2009 Jan; 250(1):130-6. PubMed ID: 19017926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the artifacts caused by metallic implants in breast MRI using dual-echo dixon versus conventional fat-suppression techniques.
    Le Y; Kipfer HD; Majidi SS; Holz S; Lin C
    AJR Am J Roentgenol; 2014 Sep; 203(3):W307-14. PubMed ID: 25148189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.
    McPherson S; Jonsson JR; Cowin GJ; O'Rourke P; Clouston AD; Volp A; Horsfall L; Jothimani D; Fawcett J; Galloway GJ; Benson M; Powell EE
    J Hepatol; 2009 Aug; 51(2):389-97. PubMed ID: 19505740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two- versus three-dimensional dual gradient-echo MRI of the liver: a technical comparison.
    Fischer MA; Donati OF; Chuck N; Blume IN; Hunziker R; Alkadhi H; Nanz D
    Eur Radiol; 2013 Feb; 23(2):408-16. PubMed ID: 22865276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fat-suppressed three-dimensional dual echo Dixon technique for contrast agent enhanced MRI.
    Ma J; Vu AT; Son JB; Choi H; Hazle JD
    J Magn Reson Imaging; 2006 Jan; 23(1):36-41. PubMed ID: 16315212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.